Scotia Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Scotia Capital's ZBH Position: Q2 2026 in Review
Scotia Capital reduced its Zimmer Biomet (ZBH) stake by 29% in Q2 2026, selling an estimated $144K and leaving 3,952 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #770.
Scotia Capital first reported a position in ZBH in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.88M in Q4 2022. 908 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Scotia Capital held 3,952 shares of Zimmer Biomet worth $340K as of Q2 2026.
- Scotia Capital sold 1,638 Zimmer Biomet shares in Q2 2026, an estimated $144K.
- Zimmer Biomet made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #770 holding.
- Scotia Capital first reported a position in Zimmer Biomet in Q3 2020 and has held it in 16 quarters since.
- Scotia Capital's Zimmer Biomet position peaked at $1.88M in Q4 2022.
- 908 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.